FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Allogene Fast Track for Renal Cell Carcinoma Drug

Allogene Therapeutics receives an FDA fast track designation for its allogeneic CAR T product (ALLO-316) for treating patients with advanced or metast...

Medical Devices

Warning on ACON Biotech Covid Tests

FDA issues a warning against using ACON Biotech Covid-19 tests due to false results concerns.

Human Drugs

Venatorx Pharma Plans NDA for Infection Fighter

Venatorx Pharmaceuticals plans a fourth quarter NDA submission following positive results from its pivotal Phase 3 study evaluating cefepime-taniborba...

Human Drugs

FDA Sets PDUFA Target Date for Acadia Nuplazid sNDA

FDA says it will act on 8/4 on an Acadia Pharmaceuticals resubmitted sNDA for Nuplazid to treat hallucinations and delusions associated with Alzheimer...

Biologics

Judge Approves StemGenex Client Settlement

A California federal judge approves a $3.65 million settlement between the defunct StemGenex stem cell clinic and 1,063 former clients who said they w...

Human Drugs

Look Into PBM Competitive Concerns: Grassley

Sen. Charles Grassley calls on the Federal Trade Commission to overcome a deadlocked vote and initiate a study into the business practices of pharmacy...

Federal Register

Draft Guide on Drug Supplier Verification Systems

Federal Register notice: FDA makes available a revised draft guidance entitled Verification Systems Under the Drug Supply Chain Security Act for Certa...

Human Drugs

Zydus/Cadila Gets FDA-483 After Inspection

FDA issued Zydus Lifesciences (formerly known as Cadila Healthcare) a three-item Form FDA-483 after recently inspecting the firms Jarod, Gujarat (Indi...

Federal Register

Oncologic Panel Meeting to Review Ukoniq sNDA

Federal Register notice: FDA has announces a 4/21-22 Oncologic Drugs Advisory Committee meeting that will discuss the appropriate approach for phospha...

Human Drugs

Cape Drugs FDA-483

FDA releases the FDA-483 with four observations issued following an inspection at Annapolis, MD-based Cape Drugs.